Mirvaso
Showing 1 - 13 of 13
Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE)
Completed
- Rosacea
- Mirvaso® / Onreltea TM
-
Hamilton, CanadaInvestigator site 1
May 6, 2021
Rosacea Trial in Canada, United States (Brimonidine 0.33% gel (Br), CD07805/47 (Br) gel, Ivermectin 1% cream (IVM))
Completed
- Rosacea
- Brimonidine 0.33% gel (Br)
- +3 more
-
Fort Smith, Arkansas
- +12 more
Feb 16, 2021
Intraocular Pressure Trial in Winston-Salem (Brimonidine, Tropicamide, Phenylephrine Ophthalmic Product)
Completed
- Intraocular Pressure
- Brimonidine
- +2 more
-
Winston-Salem, North CarolinaWake Forest Baptist Medical Center
Jul 27, 2020
Flushing, Alcohol-Related Disorders, Aldehyde Dehydrogenase Deficiency Trial in San Francisco (Brimonidine Tartrate, Placebo
Completed
- Flushing
- +2 more
- Brimonidine Tartrate
- Placebo Vehicle Gel
-
San Francisco, CaliforniaUC, San Francisco
Apr 30, 2020
Rosacea Trial in Winston-Salem (brimonidine topical gel 0.33% & survey, brimonidine topical gel 0.33% & SOC)
Completed
- Rosacea
- brimonidine topical gel 0.33% & survey
- brimonidine topical gel 0.33% & SOC
-
Winston-Salem, North CarolinaDept of Dermatology, WFUHS
Sep 10, 2018
Presbyopia, Pseudophakia Trial in Boston (Brimonidine, pilocarpine)
Unknown status
- Presbyopia
- Pseudophakia
- Brimonidine, pilocarpine
-
Boston, MassachusettsMassachusetts Eye and Ear
Jan 30, 2019
Hand-foot Syndrome Trial in Düsseldorf (Brimonidine Tartrate)
Terminated
- Hand-foot Syndrome
- Brimonidine Tartrate
-
Düsseldorf, GermanyUniversitätsklinikum Düsseldorf, Klinik für Dermatologie
Jan 7, 2019
Erythema and Flushing Associated With Rosacea Trial (Mirvaso® (brimonidine) topical gel, 0.33%, Dysport®, Dysport® in
Terminated
- Erythema and Flushing Associated With Rosacea
- Mirvaso® (brimonidine) topical gel, 0.33%
- +2 more
- (no location specified)
Apr 16, 2018
Telangiectasias Trial in Copenhagen NV (Brimonidine, IPL+air-cooling)
Completed
- Telangiectasias
- Brimonidine
- IPL+air-cooling
-
Copenhagen NV, DenmarkBispebjerg Hospital
Jan 3, 2018
Chronic Persistent Vascular Facial Erythema Trial in Brazil (brimonidine tartrate)
Completed
- Chronic Persistent Vascular Facial Erythema
- brimonidine tartrate
-
Rio de Janeiro, RJ, Brazil
- +4 more
Apr 5, 2017
Relapsing-Remitting Multiple Sclerosis (RRMS) Trial (peginterferon beta-1a, brimonidine tartrate, Vehicle Gel)
Withdrawn
- Relapsing-Remitting Multiple Sclerosis (RRMS)
- peginterferon beta-1a
- +2 more
- (no location specified)
Apr 21, 2016